Dexa Group, the leading pharmaceutical company from Indonesia, is ramping up its business in Southeast Asia with the launch of Glorious Dexa Singapore, Pte. Ltd. (GDS) based in Singapore. Dexa Group has exported medicines to...
The Ministry of Industry continues to improve the competitiveness of the national industry through the transformation towards industry 4.0. In this regard, as a leading international pharmaceutical company in Indonesia, Dexa Group has implemented Industry 4.0 in the...
Regdanvimab (RegkironaTM) is recommended to treat confirmed COVID-19 in adult patients who do not require supplemental oxygen therapy and are at high risk of progressing to severe COVID-19. The recommended dosage of Regdanvimab is a single intravenous infusion of 40...
Entering the month of Ramadan, breastfeeding mothers or mothers are often hit by concerns regarding the adequacy of milk production needed by the baby. Even though this can be overcome by making a number of preparations so that even though they are fasting, the...
Indonesia is the Official Partner Country in the 2021 Hannover Messe. During the 72 years of holding the Hannover Messe, the health sector appeared for the first time this year and Dexa Group took part. Dexa Group carries the proud product of the innovation of the...
Police officers and health workers as the front line in the implementation of the Covid-19 vaccine need to get maximum protection. In addition to using personal protective equipment (PPE) and implementing health protocols, maximum protection for the body's immune...
Over the last 17 years, based on the Marketing Authorization Number (NIE) registered in the National Agency of Drugs and Food Control (BPOM), Indonesia records 23 traditional medicines classified as phytopharmaceuticals. Stimuno has been one of the first...
The support for Indonesia Indigenous Modern Medicine (OMAI) to be included in the National Health Insurance (JKN) program continues to be supported. This support surfaced in the 2nd Webinar Series held by the University of Indonesia Board of Trustees (MWA UI) with the...
Indonesia needs more scientist in the health sector to address various health problems, especially related to the Covid-19 pandemic. For information, the total number of researchers in Indonesia is still minimal. According to the 2017-2045 National Research Master...
Indonesia Indigenous Modern Medicine (OMAI) has been proven preclinically and clinically for the treatment or therapy of disease. At the 2021 Indonesian Medical Herbal Medicine Association Annual Scientific Meeting (PIT PDHMI), scientists and also health practitioners...